AAAAAA
Results:
1-21
|
Results: 21
Authors:
Arruda, VR
Fields, PA
Milner, R
Wainwright, L
De Miguel, MP
Donovan, PJ
Herzog, RW
Nichols, TC
Biegel, JA
Razavi, M
Dake, M
Huff, D
Flake, AW
Couto, L
Kay, MA
High, KA
Citation: Vr. Arruda et al., Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males, MOL THER, 4(6), 2001, pp. 586-592
Authors:
Herzog, RW
Mount, JD
Arruda, VR
High, KA
Lothrop, CD
Citation: Rw. Herzog et al., Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation, MOL THER, 4(3), 2001, pp. 192-200
Authors:
Fields, PA
Arruda, VR
Armstrong, E
Chu, K
Mingozzi, F
Hagstrom, JN
Herzog, RW
High, KA
Citation: Pa. Fields et al., Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9, MOL THER, 4(3), 2001, pp. 201-210
Authors:
High, KA
Citation: Ka. High, Gene therapy: a 2001 perspective, HAEMOPHILIA, 7, 2001, pp. 23-27
Authors:
Fields, PA
Armstrong, E
Hagstrom, JN
Arruda, VR
Murphy, ML
Farrell, JP
High, KA
Herzog, RW
Citation: Pa. Fields et al., Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice, GENE THER, 8(5), 2001, pp. 354-361
Authors:
High, KA
Citation: Ka. High, Gene transfer as an approach to treating hemophilia, CIRCUL RES, 88(2), 2001, pp. 137-144
Authors:
Hung, HL
Pollak, ES
Kudaravalli, RD
Arruda, V
Chu, K
High, KA
Citation: Hl. Hung et al., Regulation of human coagulation factor X gene expression by GATA-4 and theSp family of transcription factors, BLOOD, 97(4), 2001, pp. 946-951
Authors:
Arruda, VR
Hagstrom, JN
Deitch, J
Heiman-Patterson, T
Camire, RM
Chu, K
Fields, PA
Herzog, RW
Couto, LB
Larson, PJ
High, KA
Citation: Vr. Arruda et al., Posttranslational modifications of recombinant myotube-synthesized human factor IX, BLOOD, 97(1), 2001, pp. 130-138
Authors:
Fields, PA
Kowalczyk, DW
Arruda, VR
Armstrong, E
McCleland, ML
Hagstrom, JN
Pasi, KJ
Ertl, HCJ
Herzog, RW
High, KA
Citation: Pa. Fields et al., Role of vector in activation of T cell subsets in immune responses againstthe secreted transgene product factor IX, MOL THER, 1(3), 2000, pp. 225-235
Authors:
Kay, MA
Manno, CS
Ragni, MV
Larson, PJ
Couto, LB
McClelland, A
Glader, B
Chew, AJ
Tai, SJ
Herzog, RW
Arruda, V
Johnson, F
Scallan, C
Skarsgard, E
Flake, AW
High, KA
Citation: Ma. Kay et al., Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector, NAT GENET, 24(3), 2000, pp. 257-261
Authors:
Herzog, RW
Arruda, VR
Fisher, TH
Read, MS
Nichols, TC
High, KA
Citation: Rw. Herzog et al., Absence of circulating factor IX antigen in hemophilia B dogs of the UNC-Chapel Hill colony, THROMB HAEM, 84(2), 2000, pp. 352-354
Authors:
High, KA
Citation: Ka. High, Gene therapy in haematology and oncology, LANCET, 356, 2000, pp. S8-S8
Authors:
Gollapalli, U
Dantus, MM
High, KA
Citation: U. Gollapalli et al., Environment and control issues in design, COMPUT CH E, 24(2-7), 2000, pp. 1709-1712
Authors:
Hagstrom, JN
Couto, LB
Scallan, C
Burton, M
McCleland, ML
Fields, PA
Arruda, VR
Herzog, RW
High, KA
Citation: Jn. Hagstrom et al., Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter, BLOOD, 95(8), 2000, pp. 2536-2542
Authors:
Camire, RM
Larson, PJ
Stafford, DW
High, KA
Citation: Rm. Camire et al., Enhanced gamma-carboxylation of recombinant factor X using a chimeric construct containing the prothrombin propeptide, BIOCHEM, 39(46), 2000, pp. 14322-14329
Authors:
Herzog, RW
Yang, EY
Couto, LB
Hagstrom, JN
Elwell, D
Fields, PA
Burton, M
Bellinger, DA
Read, MS
Brinkhous, KM
Podsakoff, GM
Nichols, TC
Kurtzman, GJ
High, KA
Citation: Rw. Herzog et al., Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector, NAT MED, 5(1), 1999, pp. 56-63
Authors:
Mendes, LJ
Tsai, TC
High, KA
High, MS
Tree, DA
Citation: Lj. Mendes et al., Model of processing-induced microstructure formation in polymeric materials, J POL SC PP, 37(18), 1999, pp. 2571-2585
Authors:
Herzog, RW
High, KA
Citation: Rw. Herzog et Ka. High, Adeno-associated virus-mediated gene transfer of factor IX for treatment of hemophilia B by gene therapy, THROMB HAEM, 82(2), 1999, pp. 540-546
Authors:
Dantus, MM
High, KA
Citation: Mm. Dantus et Ka. High, Evaluation of waste minimization alternatives under uncertainty: a multiobjective optimization approach, COMPUT CH E, 23(10), 1999, pp. 1493-1508
Authors:
Stanley, TB
Humphries, J
High, KA
Stafford, DW
Citation: Tb. Stanley et al., Amino acids responsible for reduced affinities of vitamin K-dependent propeptides for the carboxylase, BIOCHEM, 38(47), 1999, pp. 15681-15687
Authors:
Hagstrom, JN
Walter, J
Bluebond-Langner, R
Amatniek, JC
Manno, CS
High, KA
Citation: Jn. Hagstrom et al., Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease, J PEDIAT, 133(6), 1998, pp. 777-781
Risultati:
1-21
|